Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2017-12-22

FDA Approved: OXYBUTYNIN CHLORIDE — Original Application (KVK-Tech, Inc.)

View source ↗

Summary

FDA approved the original application for a generic oxybutynin chloride product from KVK-Tech, Inc. for the treatment of overactive bladder.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Oxybutynin chloride (Oxybutynin chloride)

Snippet

ORIG AP for OXYBUTYNIN CHLORIDE (OXYBUTYNIN CHLORIDE)